The therapeutic effect of cannabidiol in oral mucosa lesions

Aim: This study aims to analyze the potential therapeutic effect of cannabidiol use on oral mucosa lesions in clinical and in vivo studies. Methods: A scoping review was conducted considering the question: “Is there a therapeutic effect of the use of cannabidiol (CBD) on lesions of the oral mucosa?”. Four distinct databases were searched (PubMed/MEDLINE, Embase, Web of Science, and Scopus) and gray literature until August 2023. Original clinical and in vivo studies were included, involving human and animal subjects where CBD was applied topically to the oral mucosa or administered systemically for the treatment of lesions or superficial/deep alterations of the oral mucosa. Results: A total of 610 records were found in the initial searches. Twelve studies were assessed in full text for eligibility and five studies were excluded. Seven studies were included in this review. Five studies were conducted with in vivo design and only two studies had clinical design in humans. Considering results from in vivo studies, all of them presented better clinical results for oral mucosa lesion groups treated with CBD-based therapy compared to placebo. Regarding histological features, four studies found statistically significant improvement in CBD-based therapy and only one study did not find a significant improvement. For clinical studies, all studies presented positive clinical results (primarily regarding pain control) in the use of CBD-based therapies. Conclusion: CBD appears effective in treating oral mucosa lesions (oral mucositis, ulcers, burning mouth syndrome). CBD-based therapies can reduce inflammation in vivo studies and hold promise for pain control and lesion healing in oral mucosa lesions in clinical studies. However, the limited number of clinical trials, heterogeneity in cannabis-based therapies, and a lack of standardized protocols underscore the need for further rigorous, interdisciplinary research to establish consistent dosing and assess the efficacy of various cannabinoids in treating oral mucosa conditions.

Authors

Institutions

Publication Details

Journal
Brazilian journal of oral sciences/Brazilian Journal of Oral Sciences
Published
2025-03-28
DOI
https://doi.org/10.20396/bjos.v24i00.8675518
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The therapeutic effect of cannabidiol in oral mucosa lesions

Luiz Alexandre Chisini, Luana Carla Salvi, Matías Mederos
Brazilian journal of oral sciences/Brazilian Journal of Oral Sciences
Cannabis and Cannabinoid Research
article

The therapeutic effect of cannabidiol in oral mucosa lesions

Luiz Alexandre Chisini, Luana Carla Salvi, Matías Mederos
article en

Abstract

Aim: This study aims to analyze the potential therapeutic effect of cannabidiol use on oral mucosa lesions in clinical and in vivo studies. Methods: A scoping review was conducted considering the question: “Is there a therapeutic effect of the use of cannabidiol (CBD) on lesions of the oral mucosa?”. Four distinct databases were searched (PubMed/MEDLINE, Embase, Web of Science, and Scopus) and gray literature until August 2023. Original clinical and in vivo studies were included, involving human and animal subjects where CBD was applied topically to the oral mucosa or administered systemically for the treatment of lesions or superficial/deep alterations of the oral mucosa. Results: A total of 610 records were found in the initial searches. Twelve studies were assessed in full text for eligibility and five studies were excluded. Seven studies were included in this review. Five studies were conducted with in vivo design and only two studies had clinical design in humans. Considering results from in vivo studies, all of them presented better clinical results for oral mucosa lesion groups treated with CBD-based therapy compared to placebo. Regarding histological features, four studies found statistically significant improvement in CBD-based therapy and only one study did not find a significant improvement. For clinical studies, all studies presented positive clinical results (primarily regarding pain control) in the use of CBD-based therapies. Conclusion: CBD appears effective in treating oral mucosa lesions (oral mucositis, ulcers, burning mouth syndrome). CBD-based therapies can reduce inflammation in vivo studies and hold promise for pain control and lesion healing in oral mucosa lesions in clinical studies. However, the limited number of clinical trials, heterogeneity in cannabis-based therapies, and a lack of standardized protocols underscore the need for further rigorous, interdisciplinary research to establish consistent dosing and assess the efficacy of various cannabinoids in treating oral mucosa conditions.

Brazilian journal of oral sciences/Brazilian Journal of Oral SciencesVol. 24
Universidade Federal de Pelotas (BR), Universidad de la República de Uruguay (UY), Universidad La República (CL)
Openalex Percentile: Top 92%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.